Clinical Trial Update: Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 trial evaluating low-dose decitabine versus standard supportive care in older patients with myelodysplastic syndromes, with status cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 3 | Status: UNKNOWN